Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Clinical trial NCT00868959 · COMPLETED

Trial details

NCT number: NCT00868959
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression

Start date: 2009-04-01
Primary completion: 2013-02-01
Enrollment: 817

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.